Drugs / NT-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06704009 | Mar → Dec 2025 | wet macular degeneration | NexThera Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NT-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06704009 ↗ |
| Route | Topical | “NT-101 Topical Ophthalmic Solution” NCT06704009 ↗ |